telehealth glp-1 crackdown news today Foundayo Takes Off, & FDA Warning! The FDA is cracking down

If you lost access to semaglutide or tirzepatide, you have options.

After a two-year-long shortage, the FDA announced that Eli Lillys GLP-1 drug Mounjaro, and obesity version Zepbound, are back in stock.

Ozempic face and facial aging have been observed as side effects in many patients after glucagon like peptide 1 receptor agonists (GLP-1RA) therapy for type 2 diabetes mellitus (T2DM) and obesity

Licensed physicians, no hidden fees, 24/7 support.

Provocan nuseas en el 40% de los casos, vmitos en el 25% y trastornos del trnsito en el 23% de los pacientes

While drug manufacturers sometimes offer discount programs, consumers are often left paying hundreds of dollars out of pocket for their prescriptions